Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Allegiant's October 2025 Traffic Numbers Improve Year Over Year
Allegiant's October 2025 Traffic Numbers Improve Year Over Year

Allegiant Travel Company ALGT recently reported encouraging traffic numbers for October 2025. 

Scheduled traffic (measured in revenue passenger miles) rose 25.8% from the October 2024 levels

Softer-Than-Expected Initial Claims
Softer-Than-Expected Initial Claims

Pre-market futures are in the green again this hour and holding steady through the release of a few key pieces of data this morning. This follows a highly successful trading day, up half a point to

Palantir vs. SoFi: Which High-Growth Tech Stock is the Better Buy Now?
Palantir vs. SoFi: Which High-Growth Tech Stock is the Better Buy Now?

Both Palantir Technologies Inc. PLTR and SoFi Technologies, Inc. SOFI are fast-growing, innovation-driven technology companies deeply focused on using data, software, and advanced automation to

Meta Platforms' Ad Revenue Growth Picks Up: More Upside Ahead?
Meta Platforms' Ad Revenue Growth Picks Up: More Upside Ahead?

Meta Platforms META generates most of its revenues from advertising. In the third quarter of 2025, advertising revenues accounted for 98.6% of Family of Apps revenues and 97.7% of third-quarter

AI Earnings Roundup: NVIDIA & Palantir
AI Earnings Roundup: NVIDIA & Palantir

The 2025 Q3 earnings cycle continues to chug along, with the vast majority of S&P 500 companies already delivering results. The period has so far been one of resilience, with overall growth

BABA Q2 Earnings Miss Estimates, Revenues Increase Y/Y
BABA Q2 Earnings Miss Estimates, Revenues Increase Y/Y

Alibaba BABA reported non-GAAP earnings of 61 cents per ADS in the second quarter of fiscal 2026, which lagged the Zacks Consensus Estimate by 7.58%. In domestic currency, the company reported

Margins Flat, Innovation High: Is PG Trading Growth for Stability?
Margins Flat, Innovation High: Is PG Trading Growth for Stability?

The Procter & Gamble Company PG opened its latest quarter with solid execution but a noticeably cautious growth profile, raising the question of whether the company is prioritizing stability over

Soundhound, Parkopedia Partners on a New AI Parking Voice Assist
Soundhound, Parkopedia Partners on a New AI Parking Voice Assist

SoundHound AI, Inc. SOUN has entered into a partnership with Parkopedia to offer a new in-vehicle voice AI parking agent within its in-car voice commerce platform.This expanded collaboration with

DKS Q3 Earnings Top Estimates, Foot Locker Acquisition Lifts Outlook
DKS Q3 Earnings Top Estimates, Foot Locker Acquisition Lifts Outlook

DICK'S Sporting Goods, Inc. DKS posted robust third-quarter fiscal 2025 results, wherein the top and bottom lines beat the Zacks Consensus Estimate. Both sales and earnings increased from the

SHOP's Merchant Solutions Surge: Is GMV Strength Driving More Upside?
SHOP's Merchant Solutions Surge: Is GMV Strength Driving More Upside?

Shopify’s SHOP accelerating GMV momentum continues to fuel significant upside in Merchant Solutions, its largest and most dynamic revenue engine. A robust 32% GMV surge underscores how transaction

Goldman vs. Morgan Stanley: Which Stock Has Stronger Upside?
Goldman vs. Morgan Stanley: Which Stock Has Stronger Upside?

As global dealmaking activity picks up, the spotlight is once again on Wall Street’s most dominant investment banks: Goldman Sachs GS and Morgan Stanley MS. Both firms stand to benefit from an

Workday Q3 Earnings Beat Estimates on Solid Revenue Growth
Workday Q3 Earnings Beat Estimates on Solid Revenue Growth

Workday, Inc. WDAY reported strong third-quarter fiscal 2026 results, with the bottom and top lines beating the respective Zacks Consensus Estimate. The company reported revenue growth year over

BASFY Launches Advanced Dispersant Production Line in China
BASFY Launches Advanced Dispersant Production Line in China

BASF SE BASFY has commissioned a new high-performance dispersant production line at the Jiangbei New Material Technology Park in Nanjing, China. This expansion uses Controlled Free Radical

Battle of Benefits: Will UNH Deliver the Bigger Dose or CVH?
Battle of Benefits: Will UNH Deliver the Bigger Dose or CVH?

In a healthcare landscape defined by scale, integration and data-driven care, UnitedHealth Group Incorporated UNH and CVS Health Corporation CVS stand out as two of the most powerful players in the

Roper's Application Software Strength Holds Firm: More Upside Ahead?
Roper's Application Software Strength Holds Firm: More Upside Ahead?

Roper Technologies, Inc. ROP is benefiting from solid momentum in the Application Software segment, driven by strength in the acute healthcare, property and casualty insurance and legal markets. In

Plug Power vs. Flux Power: Which Clean Energy Stock Has the Edge?
Plug Power vs. Flux Power: Which Clean Energy Stock Has the Edge?

Plug Power Inc. PLUG and Flux Power Holdings, Inc. FLUX are both prominent names operating in the clean energy market. As rivals, these companies are engaged in manufacturing advanced energy storage

Nu vs. OppFi: Which Fintech Lender Offers Better Upside Now?
Nu vs. OppFi: Which Fintech Lender Offers Better Upside Now?

Both OppFi Inc. OPFI and Nu Holdings Ltd. NU are fintech companies that specialize in consumer lending for the underserved population and emerging credit markets.

We have analyzed both stocks to

Strength in Aerospace Segment Drives Honeywell: Can the Momentum Sustain?
Strength in Aerospace Segment Drives Honeywell: Can the Momentum Sustain?

Honeywell International Inc. HON is benefiting from persistent strength in the Aerospace Technologies segment. Organic revenues from the segment increased 12% year over year in the third quarter of

ConocoPhillips or ExxonMobil: Which Oil Major Looks Stronger Today?
ConocoPhillips or ExxonMobil: Which Oil Major Looks Stronger Today?

ExxonMobil Corporation XOM and ConocoPhillips COP are major energy giants, both having a strong upstream presence. Over the past year, ExxonMobil has gained 2.2%, outpacing the 15.6% decline of COP.

NOC Secures a Contract to Aid Stand-In Attack Weapon Subsystem
NOC Secures a Contract to Aid Stand-In Attack Weapon Subsystem

Northrop Grumman NOC recently secured a $100 million contract to provide active-seeker–related support. This includes work on components, testing and evaluation services and science and technology

Primoris Services vs. MasTec: Which Construction Stock to Bet on Now?
Primoris Services vs. MasTec: Which Construction Stock to Bet on Now?

The robust public infrastructure spending environment is benefiting firms operating in the infrastructure and specialty-construction markets focused on utilities, energy, pipeline and heavy civil

NVO Stock Up as Amycretin Shows Strong Weight Loss in Type 2 Diabetes
NVO Stock Up as Amycretin Shows Strong Weight Loss in Type 2 Diabetes

Shares of Novo Nordisk NVO were up 4.7% yesterday, after the company announced positive data from a phase II study evaluating its investigational pipeline candidate, amycretin, in people with type 2

NIO Q3 Loss Narrower Than Expected, Revenues Increase Y/Y
NIO Q3 Loss Narrower Than Expected, Revenues Increase Y/Y

NIO Inc. NIO reported a loss per American Depositary Share (ADS) of 21 cents in the third quarter of 2025, narrower than the Zacks Consensus Estimate of a loss of 24 cents. The company had incurred

Market Participants Thankful Ahead of the Open
Market Participants Thankful Ahead of the Open

Wednesday, November 26, 2025Pre-market futures are in the green again this hour and holding steady through the release of a few key pieces of data this morning. This follows a highly successful

AbbVie and Pfizer: A Closer Look at Two Pharma Heavyweights
AbbVie and Pfizer: A Closer Look at Two Pharma Heavyweights

Pfizer PFE and AbbVie ABBV are both U.S. pharmaceutical giants with a strong leadership position in various therapeutic areas. For Pfizer, oncology sales comprise around 28% of its total revenues